
BioTrillion is a MedtechAI startup focused on revolutionizing healthcare by transforming smartphones into powerful diagnostic tools. Their core technology, BioEngine4D™, analyzes physiological data from a user's face using AI and computer vision, enabling the detection of diseases from everyday smartphone use. Their HealthySelfie™ app can extract 10 health vitals and disease biomarkers from a 10-second selfie video with an average accuracy of 91%, making health monitoring accessible to billions. The company operates across the healthcare continuum, from prevention to intervention, aiming to provide early disease detection and data-driven drug development solutions. Their business model appears to be software-based, leveraging existing smartphone technology for scalability without requiring new hardware.

BioTrillion is a MedtechAI startup focused on revolutionizing healthcare by transforming smartphones into powerful diagnostic tools. Their core technology, BioEngine4D™, analyzes physiological data from a user's face using AI and computer vision, enabling the detection of diseases from everyday smartphone use. Their HealthySelfie™ app can extract 10 health vitals and disease biomarkers from a 10-second selfie video with an average accuracy of 91%, making health monitoring accessible to billions. The company operates across the healthcare continuum, from prevention to intervention, aiming to provide early disease detection and data-driven drug development solutions. Their business model appears to be software-based, leveraging existing smartphone technology for scalability without requiring new hardware.
Business: Medtech/HealthAI startup converting smartphones into diagnostic tools via computer vision
Core product: BioEngine4D (HealthySelfie) — extracts ~10 vitals/biomarkers from short selfie videos
Founded / HQ: Founded 2018; headquartered in San Francisco, CA
Team size (reported): 5 employees
Funding: Seed round reported Aug 15, 2018; total disclosed funding reported as $3,000,000 (USD) in evidence
Remote patient monitoring, digital biomarkers, early disease detection, and data-driven drug development
2018
Medtech / HealthAI
Seed round reported with seven investors; specific round amount obfuscated in some sources
“David B. Kirk; Santosh Kumar; Tom X. Lee; SVTC + Constellar Ventures; Savan Devani; Lu Yoh-Chie; Government of United States of America”